Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up
The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal with regulators, including the US FDA, and set themselves on a high-growth path. Today, some of these companies are big, mostly dominating the generics space. And this week we just witnessed an event that may mark a watershed moment for the sector: Sun Pharma’s acquisition of the US Organon. Why so?
The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal with regulators, including the US FDA, and set themselves on a high-growth path. Today, some of these companies are big, mostly dominating the generics space. And this week we just witnessed an event that may mark a watershed moment for the sector: Sun Pharma’s acquisition of the US Organon. Why so?
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
